Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT06933914 · RECRUITING
Trial details
- NCT number
- NCT06933914
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-30
- Primary completion
- 2026-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.